Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 24, 1999

View Archived Issues

SR Pharma Enters Deal With Sakai, Completes

Rearranged Telomeres May Be A Link To Mental Retardation

Irish Biotechnology Sector Facing Famine In Financing

EC Seeks Broader Support For Positions At World Trade Talks

genOway Seeks To Accelerate Genetics-Based Development

XTL Partners With Roche To Test Hepatitis C Drug

Cyclacel Recipient Of Fund To Boost Scottish Biotech

Canadian Scientists Find A Trigger For Bone Destruction

Other News To Note

Scotia Gains Orphan Status For Photodynamic Therapy

IDM Opens New Laboratory On Site Of Paris University

Oxford Glycosciences Finds Differences In Two Cell Types

Otogene Getting Funding To Develop Hearing Loss Drugs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...